EP

Emil Pot

Business Development at Oncode Institute

Emil Pot is the Co-Founder and CEO of Allero Therapeutics, a company that develops immunotherapies for allergic and autoimmune disease patients. Emil also holds a position in business development at Oncode Institute, an independent research institute focused on cancer research. Prior to this, Emil worked as a European Patent Attorney and in business development at NLO, a firm specializing in intellectual property. Emil was also a Co-Founder and General Counsel at ActoGeniX N.V. before its successful acquisition. With a background in law and patents, Emil has extensive experience in business development, patent law, and technology transfer.

Location

Ghent, Belgium

Links

Previous companies

VIB BV logo

Org chart

Sign up to view 0 direct reports

Get started



Offices

This person is not in any offices